Perrigo

PRGO US Health Care Pharmaceuticals
S&P 600
$13.66
+0.52%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Current assets comfortably cover current liabilities (current ratio 2.76).
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Higher leverage: debt-to-equity of 1.45 is above 1.
  • Return on equity is on the lower side at -56.7%.
  • Return on capital employed is on the lower side at -17%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
-0.09

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Piotroski F-ScoreModerate
4 / 8

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 8 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$1.89B
Current Price$ 13.66
High / Low$ 22.65 / 9.23
Stock P/E-1.33
Book Value$ 18.02
Dividend Yield8.54%
ROCE-17.01%
ROE-56.66%
Debt to Equity1.45
Current Ratio2.76
P/B Ratio0.753115
EPS$ -10.29
Debt$3.64B
PAT Margin-33.51%
Cash PAT$-1.09B
Educational data only. Not a recommendation to buy, sell or hold any security.